Camp4 affiliate plans sale of 1,738 CAMP shares

Camp4 Therapeutics Corp (CAMP) received a notice that affiliate Daniel Tardiff, through J.P.

Rhea-AI Filing Summary

Camp4 Therapeutics Corp (CAMP) received a notice that affiliate Daniel Tardiff, through J.P. Morgan Securities LLC as agent, plans to sell 1,738 shares of common stock under Rule 144. The proposed sale is valued at approximately $8,275.55 with an anticipated sale date of August 19, 2026. The filing also notes an earlier 434-share ESPP issuance on July 2, 2026 for cash.

Key Figures

Shares proposed to be sold: 1,738 shares Approximate market value of shares: $8,275.55 Approximate date of sale: 08/19/2026 +2 more

5 metrics

Shares proposed to be sold 1,738 shares Common stock to be sold under Rule 144 for the account of Daniel Tardiff

Approximate market value of shares $8,275.55 Value of 1,738 Camp4 Therapeutics common shares covered by the planned sale

Approximate date of sale 08/19/2026 Anticipated sale date for the 1,738 shares of common stock

ESPP issuance shares 434 shares Camp4 Therapeutics common stock issued via ESPP on 07/02/2026 for cash

Issuer phone 6176518867 Contact phone number for Camp4 Therapeutics Corporation

Key Terms

Rule 144, affiliate, ESPP Issuance, Attorney in Fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"In addition, information shall be given as to sales by all persons... affiliate"

ESPP Issuance financial

"Common | 07/02/2026 | 434 ESPP Issuance | Camp4 Therapeutics"

Attorney in Fact regulatory

"J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Daniel Tardiff"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filed for CAMP indicate about planned stock sales?

The Form 144 reports a planned sale of 1,738 shares of Camp4 Therapeutics common stock by affiliate Daniel Tardiff. J.P. Morgan Securities LLC will act as agent, with an estimated value of $8,275.55 and an anticipated sale date of August 19, 2026.

Who is selling Camp4 Therapeutics (CAMP) shares under this Form 144?

The notice covers shares for the account of Daniel Tardiff, identified as an affiliate of Camp4 Therapeutics. J.P. Morgan Securities LLC, Workplace Solutions, is acting as agent and attorney in fact to execute the planned Rule 144 sale of common stock.

How many CAMP shares are covered by the planned Rule 144 sale and what is their value?

The filing covers 1,738 shares of Camp4 Therapeutics common stock with an approximate market value of $8,275.55. These shares are expected to be sold on or about August 19, 2026 through J.P. Morgan Securities LLC on NASDAQ.

What recent equity issuance to the seller is disclosed for Camp4 Therapeutics (CAMP)?

The notice discloses a prior 434-share ESPP issuance of Camp4 Therapeutics common stock on July 2, 2026 for cash. This relates to shares acquired through an Employee Stock Purchase Plan (ESPP) before the planned Rule 144 sale.

On which market are the CAMP shares in this Form 144 expected to be sold?

The shares referenced in the Form 144 are Camp4 Therapeutics common stock listed on NASDAQ. J.P. Morgan Securities LLC is identified as the broker for the proposed sale of 1,738 shares with an estimated value of $8,275.55.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/19/2026 - 10:23 AM EDT Accepted by SEC EDGAR 08/19/2026 - 10:23 AM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002089301
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	CAMP4 Therapeutics Corporation
SEC File Number	001-42365
Address of Issuer	100 Talcott Avenue Suite 201 Watertown MASSACHUSETTS 02472
Phone	6176518867
Name of Person for Whose Account the Securities are To Be Sold	Daniel Tardiff
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	1738	8275.55	51925800	08/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/02/2026	434 ESPP Issuance	Camp4 Therapeutics			1738	07/02/2026	cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/19/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Daniel Tardiff, CAMP4 Therapeutics
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)